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Abstract
Background: Polyketides are structurally diverse natural pro-
ducts with a range of medically useful activities. Non-aromatic
bacterial polyketides are synthesised on modular polyketide
synthase multienzymes (PKSs) in which each cycle of chain
extension requires a different ‘module’ of enzymatic activities.
Attempts to design and construct modular PKSs that synthesise
specified novel polyketides provide a particularly stringent test of
our understanding of PKS structure and function.
Results : We show that the ketoreductase (KR) domains of
modules 5 and 6 of the erythromycin PKS, housed in the
multienzyme subunit DEBS3, exert an unexpectedly low level of
stereochemical control in reducing the keto group of a synthetic
analogue of the diketide intermediate. This led us to construct a
hybrid triketide synthase based on DEBS3 with ketosynthase
domain ketosynthase (KS)5 replaced by the loading module and
KS1. The construct in vivo produced two major triketide
stereoisomers, one expected and one surprising. The latter was
of opposite configuration at three out of the four chiral centres:
the branching alkyl centre was that produced by KS1 and,
surprisingly, both hydroxyl centres produced by the reduction
steps carried out by KR5 and KR6 respectively.
Conclusions: These results demonstrate that the epimerising
activity associated with module 1 of the erythromycin PKS can be
conferred on module 5 merely by transfer of the KS1 domain.
Moreover, the normally precise stereochemical control observed in
modular PKSs is lost when KR5 and KR6 are challenged by an
unfamiliar substrate, which is much smaller than their natural
substrates. This observation demonstrates that the stereochemistry
of ketoreduction is not necessarily invariant for a given KR
domain and underlines the need for mechanistic understanding in
designing genetically engineered PKSs to produce novel
products. ß 2001 Elsevier Science Ltd. All rights reserved.
Keywords: Polyketide synthase; Celmer’s rules; Hybrid polyketide
synthase; Epimerisation; KR domain
1. Introduction
Rapid progress has been made in recent years in pro-
ducing altered polyketide metabolites by genetic engineer-
ing of the enzymes responsible for their biosynthesis. In
the case of erythromycin, for example, the polyketide syn-
thase (PKS) has been modi¢ed to produce erythromycins
with altered starter acids, related polyketides with missing
branching methyl groups and also macrolide structures
with di¡erent levels of oxidation at some of the oxygen-
ated centres [1^7].
This success in altering structure has been assisted by
the modular nature of the proteins responsible for assem-
bly of the macrolide core of erythromycin and similar
natural products. In the case of erythromycin, it was
shown that the PKS is encoded by three giant genes called
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ery AI, ery AII and ery AIII respectively. Each of these is
approximately 11 kbp in length and each encodes a giant
protein consisting of approximately 3000 amino acids
[8,9], which is isolated as a homodimer [9^11]. The eryth-
romycin PKS, therefore, comprises three giant multifunc-
tional proteins, which are called DEBS1, DEBS2 and
DEBS3 (Fig. 1). The active sites (domains) housed in these
giant proteins are organised into chain extension modules,
six in total, one for each chain extension step involved in
assembly of the macrolide core. The ¢rst module is pre-
ceded by a bidomain that selects and loads a propionate
from the pool of intracellular propionyl CoA. The last
(sixth) module in DEBS3 is followed by a thioesterase
domain (TE), which releases the complete polyketide
chain, presumably by macrolide ring formation.
There is a direct correlation in the erythromycin PKS
between the domains present in each chain extension mod-
ule and the chemical processes needed to develop the
structure of the corresponding extension unit in the poly-
ketide chain. This correspondence can be understood on
the basis of the known chemistry of fatty acid biosynthesis
which proceeds by a series of repeated cycles of condensa-
Fig. 1. The erythromycin-producing PKS; primary organisation of the genes and their corresponding protein domains. There are six chain extension
modules, each beginning with a KS domain, that are responsible for adding the six successive C3 units. The loading module (LM) speci¢es propionate
as the starter unit. The completed chain is released as a macrolactome by the TE domain. KR, L-ketoacyl reductase.
Fig. 2.
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tion and reduction (Fig. 2) in which the initially formed
keto group is converted to a methylene in every chain
extension cycle. In a modular PKS, however, the extent
of reductive modi¢cation can be truncated in modules,
which lack one or more of the relevant domains. For
example, if the enoyl reductase (ER) domain is missing,
the chain extension product is a double bond; if both ER
and dehydratase (DH) are missing, as in modules 2, 5 and
6 of the erythromycin PKS then a hydroxyl group is
formed in that chain extension unit; and if all three reduc-
tive domains (DH, ER and KR) are missing, for example
in module 3 of the erythromycin PKS, a carbonyl group
remains in the developed polyketide chain. This correla-
tion makes it possible to predict, with some con¢dence,
the product a given PKS may make. It also gives a ration-
al basis for genetic engineering to alter the oxidation level
at appropriate sites of the macrolide ring [12^14]. In con-
trast, the stereochemistry at carbon centres bearing hy-
droxyl and alkyl groups produced by a PKS cannot be
predicted as yet from the gene product responsible for
chain assembly.
In a fully reduced unit, the stereochemistry at the
branching alkyl centre is determined by the reduction pro-
cess carried out by the ER domain. In the case of a hy-
droxy intermediate the chirality at the hydroxyl group
must be dictated by the KR domain. However, in this
case and in the case of a unit with a surviving keto group,
the agent of stereocontrol at the alkyl branch is not clear.
The work described in this paper was designed to contrib-
ute to a better mechanistic understanding of stereochem-
ical control in the early steps in each reduction cycle. This
in turn might allow rational alterations in PKSs, to pro-
duce predicted variations in the stereochemistry at alkyl
branching centres.
As early as 1965, Celmer noted that there is a strong,
position-speci¢c, structural and stereochemical homology
running through families of macrolides of various sizes.
Examples are shown in Fig. 3 in which representative
12-, 14- and 16-membered macrolides are compared [15].
This ¢rst suggested that there is a genetic origin for stereo-
chemical control at alkyl branching centres and, therefore,
that an understanding of how the genetic information is
correlated with chemical structure should provide a ration-
al basis for designing modi¢cations in the PKS systems
aimed at producing altered stereochemistry in polyketide
products.
In a given chain extension cycle when either a propio-
nate or butyrate chain extender is used, the ¢rst chiral
centre is established in the condensation step at the
branching methyl group in the L-keto acyl residue. Sub-
sequently, the keto group is reduced by a KR and a sec-
ond chiral centre is established. It is notable, in the case of
erythromycin, that both con¢gurations of methyl centres
are present in the polyketide chain. Referring to Fig. 1, it
can be seen that the methyl branching centre created by
module 1 has the methyl group (S)-con¢guration (pointing
down), whereas the corresponding hydroxy extension units
in modules 2, 5 and 6 all have the methyl group in the (R)-
con¢guration (pointing up). Therefore, in erythromycin,
there must be a way of developing both con¢gurations
at methyl branching sites prior to keto group reduction.
Preliminary insights into the mechanism of this stereo-
chemical control have been gained from in vitro studies
with a truncated version of the erythromycin PKS called
DEBS1-TE [16,17]. In this protein, the erythromycin PKS
was engineered so that the TE normally resident at the end
of module 6 was attached at the terminus of module 2
(Fig. 4). This gives a self-su⁄cient single multifunctional
protein which is capable of carrying out the ¢rst two chain
extensions of the erythromycin biosynthetic pathway. The
triketide products are released as N-lactones (1 and 2). This
model system produces both stereochemical possibilities at
the methyl branching centres, and is therefore an ideal
model system for probing the molecular mechanisms of
stereochemical control. The protein was isolated in pure
form and it was shown to produce the N-lactone product
in vitro in good yield when supplied with propionyl CoA,
methylmalonyl CoA and NADPH [18,19].
In the ¢rst experiments on the mechanism of stereocon-
trol, it was proved that (S)-methylmalonyl CoA was used
in both chain extension units [18,20]. In contrast, (R)-
methylmalonyl CoA was not incorporated. This showed
conclusively that the control of stereochemistry at the
methyl branching centres was not exercised by selection
of the appropriate chiral form of the chain extension
building block, as had been proposed on the basis of clas-
sical in vivo experiments [21], and re-proposed on the basis
of the existence of separate acyltransferase (AT) domains
for each cycle of chain extension in DEBS [2,22]. Instead,
the control must be exercised in the mechanisms of the
chain extension processes themselves.
Subsequently, experiments were carried out with (S)-
methylmalonyl CoA labelled at the chiral centre with deu-
Fig. 3. Comparison of the open chain of the polyketide cores of the re-
lated macrolides: (A) methymycin (12 membered macrolide); (B) eryth-
romycin (14-membered macrolide) and; (C) tylosin (16-membered mac-
rolide).
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terium. The deuterium label was retained at the methyl
branching chiral centre in the chain extension residue pro-
duced by module 2 but was completely lost in the chain
extension process carried out by module 1 [23]. These ex-
periments also showed that the chain extension reaction
was carried out with inversion of con¢guration in module
2. It was suggested, to explain the loss of the deuterium
from the chiral centre in module 1, that the equivalent
condensation step might also take place in the same ste-
reochemical sense with inversion of con¢guration to give
the (2R) isomer of the keto ester and that this isomer
would then be epimerised to the (2S) isomer by enolisation
prior to reduction by the KR domain.
These results demonstrate that module 1 holds the key
as far as alteration of stereochemistry is concerned in two
respects. First, it has to have a mechanism for carrying out
the epimerisation of the initially formed (2R) isomer of the
keto ester to the (2S) isomer. Second, some agent must be
present which selects only the (2S) isomer from the epi-
merised mixture; this is predicted to be the KR domain.
Two further experiments con¢rmed these postulates. First,
a diketide synthase was created in which there was only
one chain extension module, which combined KS1 with
the reductive loop corresponding to module 2 [24]. This
produced a diketide in which the chirality of the methyl
was opposite to that produced in module 1. This supports
the proposal that the KS1 is capable of delivering both
enantiomers of the keto ester for reduction and that KR1
selects the (S)-isomer in module 1. Further evidence to
support the proposed substrate selectivity of KR1 came
from direct studies of the stereochemistry of reduction
using a synthetic diketide keto ester analogue as substrate.
It was shown that KR1 does, indeed, select from a racemic
mixture of the N-acetyl cysteamine (NAC) derivative of
the keto ester diketide only one enantiomer (2S) and it
produces the single product corresponding to the stereo-
chemistry of reduction in module 1 [25].
What remains to be established after these experiments
is the factor in module 1 that is responsible for the epi-
merisation process. We suspected that it might be the KS
domain but it could have been any of the other domains
or even a part of the protein in the reductive loop that has
Fig. 4.
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not been assigned any speci¢c function. In order to test the
possibility that KS1 might be the active determinant of
epimerisation, we designed a hybrid PKS based on
DEBS3 in which the ¢rst KS, KS5, has been replaced by
KS1, and, to make the construct completely e⁄cient, we
also incorporated the DEBS loading module at the front
of the truncated PKS. This construct, TKS^AR1, is shown
in Fig. 5a. Since chain initiation is carried out by the
normal erythromycin starter module, it was anticipated
that both acetate and propionate would be used. The ste-
reochemical consequences of replacing KS1 by KS5 could
not be predicted for any of the chiral centres. For com-
parison, the reported pattern of behaviour of modules 5
and 6 in an unmodi¢ed version of DEBS3 is shown in Fig.
5b [26]. Since this lacks a competent starter module, it was
forced to rely on an aberrant mechanism of chain initia-
tion that speci¢ed propionate by decarboxylation of meth-
yl malonate. Only the single enantiomer (3) was reported,
corresponding to the normal stereochemical operations of
modules 5 and 6.
We were guided to this choice of model system TKS^
AR1 by the results of experiments to probe the stereose-
lectivity and stereospeci¢city of the KR domains of
DEBS3. As will be explained later, the results suggested
that one or both of these domains shows a low degree of
stereospeci¢city in carrying out reduction of the keto
group of the model keto ester. This observation raised
the interesting possibility that one or both KRs might
accept both stereoisomers of the keto ester form of the
diketide intermediate and so provide a very e¡ective ap-
proach to localise the epimerisation activity.
2. Results and discussion
2.1. Stereospeci¢city of keto group reduction by DEBS3
The experiments here followed closely on the earlier
experiments with DEBS1-TE [25]. DEBS3 was overex-
pressed in Escherichia coli [27]. The resulting enzyme was
not e⁄ciently phosphopantetheinylated on the two acyl
carrier protein (ACP) domains and so was not capable
of chain extension chemistry. However, the KR domains
were expected to be fully competent. The enzyme was in-
cubated in the presence of the NAC analogue of the keto
form of the erythromycin PKS diketide under the condi-
tions described earlier to produce reduced diketides (Fig.
6a). The reduction, monitored by consumption of
Fig. 5. Arrangement of the domains in: (a) the hybrid PKS TKS^AR1 and; (b) DEBS3.
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NADPH, was much slower than the equivalent process
with DEBS1-TE. The reduction products were then iso-
lated and analysed by chiral high performance liquid chro-
matography (HPLC); surprisingly, all four diastereoiso-
mers of the hydroxy diketide analogue were formed in
approximately equal amounts (Fig. 6b). Clearly, one or
both of the KR domains showed relaxed reaction stereo-
chemistry, either in terms of substrate selection ^ either
(2R) or (2S) keto ester is an acceptable substrate ^ or in
terms of stereochemistry of reduction ^ hydride addition
to the re or si face of the carbonyl group.
The low stereoselectivity exhibited by KR5 and KR6
towards the unnatural diketide substrate can be explained
in terms of the stereoelectronic imperatives of the reduc-
tion process, which are illustrated in Fig. 7. Hydride deliv-
ery (from the nicotinamide coenzyme) takes place to the
neighbouring face of the carbonyl group. The choice of
face is dictated by selective binding of R1 and R2 into
appropriate pockets. The developing charge on the oxygen
requires stabilisation from a strategically placed Lewis
acid (e.g. a zinc species). The extent of spatial selectivity
and hence the enantiomeric purity of the resulting carbinol
centre is determined by the ability of the enzyme active site
to discriminate between R1 and R2.
This analysis is extended in Fig. 8 to a consideration of
the binding of the diketide analogue at the active site of a
KR domain. The normal mode of binding of the natural
keto ester substrate of KR5 is mode A with hydride deliv-
ery from the lower face. In this mode the enantiomer of
the diketide is similarly bound. Normally KR5 is not con-
fronted by the 2S-con¢guration at C-2 so there is no rea-
son to expect this site to be able to discriminate between
modes A and B. The formation of the opposite enantio-
mer at C-3 can be explained by binding modes C and D in
which the direction of binding is reversed. This is equiv-
alent to a loss of ability to discriminate between the
groups R1 and R2 in Fig. 7. Note that these two groups
are similar in the diketide.
This analysis assumes that the thioester residue remains
outside the keto ester binding pocket and, therefore, does
not play a role in controlling direction of binding. It is
possible, however, that distance constraints on the phos-
phopantetheine group of the ACP would prevent the re-
verse binding mode. The lack of selectivity in the model
experiments may not apply, therefore, when the diketide
intermediate is generated on the carrier thiol group of
ACP5. So, the planned experiments test not only the abil-
ity of KS1 to e¡ect epimerisation in the hybrid module,
but also the distance constraints imposed by the £exible
arm of the ACP, which carries the growing polyketide
chain.
2.2. Design of the hybrid PKS TKS^AR1 based on DEBS3
The triketide synthase used as the test system was essen-
tially DEBS3 fronted by the loading module (AT0+ACP0)
from the erythromycin PKS but with KS5 replaced by
KS1 (Fig. 5). In order to join this ery loading ‘tridomain’
(consisting of loading module and KS of ery module 1)
with DEBS3 (minus the KS domain of module 5), a
unique HindIII site was created in the linker region (Fig.
9). A genetically engineered diketide synthase possessing a
similar junction (between the loading ‘tridomain’ and KR
domain of ery module 2) has been found to be catalyti-
cally active [24]. The unique HindIII site was created in the
gene fragment encoding DEBS3 by PCR. The forward and
reverse primers for PCR had BlpI sites. The fragment was
then cloned in pUC-18 vector, following which the 513 bp
BlpI fragment from ery module 5 was replaced by the BlpI
fragment that contained the engineered HindIII site, to
yield a plasmid that contains the gene encoding DEBS3.
Fig. 6. (a) Incubation of the NAC analogue of the keto form of the di-
ketide intermediate of the erythromycin PKS with DEBS3 yields four
reduced products. (b) Chiral HPLC trace of the product mixture pro-
duced.
Fig. 7. Stereoelectronics of reduction of a keto group by a KR. The
keto group position is determined by coordination to a metal, com-
monly zinc. Hydride is delivered to either the upper or the lower face
depending on the site of binding of the nicotinamide coenzyme (the low-
er face is arbitrarily selected in this illustration). The stereoselectivity of
the reduction process depends on the ability of the active site to dis-
criminate between R1 and R2.
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Finally, the HindIII fragment possessing this hybrid gene
was inserted into vector pIB015. This plasmid has the gene
that encodes a diketide synthase DKS1-2 (comprised of
ery loading ‘tridomain’ joined with ery module 2 and ery
TE) [24]. The resulting plasmid p015-5624 contains the
gene that would encode the hybrid PKS TKS^AR1 having
the ery loading ‘tridomain’, a truncated ery module 5 fol-
lowed by module 6 and ery TE (Fig. 5a; see Section 4 for
details of the construction of the expression plasmid p015-
5624).
2.3. Production of the triketide lactones by the hybrid
synthase TKS^AR1
Saccharopolyspora erythraea/JC2 protoplasts were trans-
formed with plasmid pO15-5624 and colonies were se-
lected by their resistance to thiostrepton upon integration
of the plasmid into the S. erythraea chromosome. S. ery-
thraea/JC2 is a mutant strain of the wild-type S. erythraea/
NRRL2338 that lacks the entire ery-PKS genes except for
the TE DNA fragment [28]. Single transformants were
picked and grown on ‘tap-water medium’ plates supple-
mented with thiostrepton, following which starter cultures
of TSB medium were inoculated from Streptomyces spore
suspensions or from patches on tap water medium plates
and growth maintained at 30‡C for 24^30 h. Solid medium
was used for growth of S. erythraea. Typically 500 cm2
sterile plates containing solid SM3 medium [29] were
spread with the starter culture (10 ml TSB) and the plates
incubated at 30‡C for 10^15 days. The solid medium was
then vortexed in water and extracted with ethyl acetate at
pH 4.0. Combined organic extracts were washed with so-
dium bicarbonate solution and evaporated to dryness in
vacuo. The resulting solid was resuspended in a small
amount of ethyl acetate. The solvent was evaporated and
a sample of each extract was analysed by gas chromatog-
raphy-mass spectrometry (GC-MS; gradient 40^145‡C in
23 min). A typical spectrum is shown in Fig. 10. The total
ion current spectrum (trace a) showed the typical complex
mixture isolated from cultures grown under these condi-
tions. The two lower traces, b and c respectively, show the
spectrum edited to select m/z 190 corresponding to trike-
tide lactone stereoisomers with a propionate starter unit (3
and 5) and m/z 176 corresponding to equivalent com-
pounds with acetate starter units (4 and 6). In both edited
spectra, all the peaks are in the range of retention times
characteristic of triketide lactone products. The two stron-
gest peaks in each spectrum gave ms/ms spectra that were
consistent with triketide lactone products. The relative
amounts of the products varied from one culture to an-
Fig. 9. Amino acid sequence around the unique HindIII fusion site introduced in the linker regions between the KS and AT domains in ery modules 1
and 5.
Fig. 8. Alternative binding modes for the ketone carbonyl of the (R)- and (S)-diketides at the active site of KR5. Hydride reduction takes place at the
lower face of the keto group in every case. A combination of all four modes produces all four stereoisomers of the reduction product.
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other. Usually, the compounds with propionate starter
units rather than acetate were the dominant species. The
relative amounts of the two main propionate-derived
products (3 and 5) remained constant at about 1:1. The
minor components were not identi¢ed but are probably
stereoisomers of the major components.
The two main propionate compounds (3 and 5) were
isolated by preparative HPLC/MS using a VG platform
mass spectrometer. The combined extracts from eight
plates were loaded onto a column of silica (14 cmU14
cm) and successive fractions eluted with diethyl ether
(400 ml), 25% ethyl acetate in diethyl ether (500 ml),
50% ethyl acetate in diethyl ether (500 ml), 75% ethyl
acetate in diethyl ether (400 ml) and ethyl acetate (400
ml). The eluent was collected in 200 ml fractions that
were analysed by GC-MS for the presence of triketide
lactone. The appropriate fractions were then concentrated
under vacuum to dryness and dissolved in 1.5 ml of HPLC
grade acetonitrile. To this was added 0.5 ml of Milli-Q
water. Batches (500 Wl) of the ¢ltered semi-pure extract
were then loaded onto a preparative LC system using a
reverse phase ODS column (25 cmU2.2 cm) and eluted
using a linear gradient of 5^30% acetonitrile in 45 min.
Fractions corresponding to the two major propionate
peaks were collected and concentrated to dryness in prep-
aration for NMR analysis.
One of the products (3) proved to be the stereoisomer
Fig. 11. Condensation and reduction cycles performed by TKS^AR1 in the biosynthesis of compounds 3^6.
Fig. 10. (a) The total ion current of a typical GC-MS trace of an ethyl
acetate extraction of S. erythraea/JC2-p015-5624. (b) GC-MS selected
for m/z = 190 corresponding to compounds 3 and 5. (c) GC-MS selected
for m/z = 176 corresponding to compounds 4 and 6.
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[(2R), (3S), (4S), (5S)]2 formed by the normal operations
of modules 5 and 6 (Fig. 11) which had been isolated
earlier in studies on triketide formation by an unmodi¢ed
version of DEBS3 [26]. This result con¢rms that KS1 can
deliver the unepimerised (2R)-keto ester to its partner KR
domain in the same module. The second major isomer (5)
was identical by proton NMR to another stereoisomer
[(2R), (3R), (4R), (5R)] also isolated in earlier work [30].
The relative stereochemistries at C-2, C-3, C-4 and C-5
were con¢rmed by molecular modelling.
There are two possible absolute con¢gurations for this
compound, either stereoisomer 5 or its enantiomer. We
feel con¢dent that the enantiomeric structure can be ex-
cluded for two reasons. First, formation of the enantiomer
of 5 would require that module 5 behaves normally,
whereas module 6 behaves abnormally. Module 5 has
two domains with compromised stereospeci¢city and so
is much more likely to be the source of stereochemical
divergence. Second, only one diastereoisomer was ob-
served in equivalent studies with DEBS3 [31]. If the enan-
tiomer of 5 had been formed in the present investigation, it
would surely have also been formed and isolated as a
major metabolite in this earlier work. Work is in progress
to con¢rm the absolute con¢guration of 5. For simplicity
in the following discussion, we will assume that 5 is the
correct con¢guration.
Compound 5 di¡ers from the ‘normal’ product at three
chiral centres. The most signi¢cant point of di¡erence in
the context of the current investigation was the stereo-
chemistry at C4 which corresponds to the (2S)-isomer pro-
duced by epimerisation of the keto ester at the methyl
branching site of the diketide formed in module 5. In
accepting this opposite epimeric form of the keto ester,
KR5 reduces the keto group not in its usual sense by
hydride addition to the re face to give the (3S)-3-hydroxy
product but in the opposite sense to give the (3R)-product
(5). Surprisingly, the reverse reduction behaviour then
continues in module 6. The condensation proceeds as ex-
pected to give the non-epimerised (2R)-keto ester but KR6
then reduces this by hydride addition not in its normal
mode to the re face but to the opposite si face. Conse-
quently, the stereochemical relationship between C-2 and
C-3 in the second chain extension unit is anti rather than
syn. Remarkably, this altered stereospeci¢city in the reduc-
tion step is triggered not by alteration of the con¢guration
at the branching methyl centre generated in the current
chain extension reaction, but by anomalous chiral centres
generated in the previous chain extension module.
That both KR5 and KR6 can reduce diketide and trike-
tide intermediates generated in situ with opposite stereo-
chemistries proves that substrate recognition and reduc-
tion at the active site are less e¡ectively controlled with
the abnormal substrates, even when the intermediates are
constrained by the phosphopantetheine chain rather than
the model NAC thioester model system.
The most signi¢cant outcome of these experiments,
however, is the demonstration that module 5 can be
turned from a non-epimerising environment to one capa-
ble of epimerisation merely by replacement of KS5 with
KS1. We believe that the two loading domains can be
excluded from this role because of the earlier work by
Katz who showed that removal of these domains from
the front of module 1 in the otherwise intact erythromycin
PKS did not destroy the epimerising activity of module 1
[32]. Our results clearly implicate KS1 as the source of
epimerising activity, although it remains to be proved
that it produces this change by acting as an active catalyst
of the epimerisation process.
In earlier NMR experiments with the keto ester diketide
as its NAC thioester, it was shown that the chiral centre
rapidly exchanged deuterium with D2O under conditions
which are considered physiological [33]. There is, there-
fore, a possibility that epimerisation is a spontaneous
chemical event which is allowed in modules which epimer-
ise and is prevented in modules which do not support
epimerisation. The mechanism of prevention could, for
example, rely on rapid transfer of the keto ester intermedi-
ate from the KS active site to the KR active site through a
channel or tunnel which excludes water and so suppresses
the spontaneous epimerisation process. De¢nition of the
precise site and timing of epimerisation will require studies
of the structure and function of the KS1 at a detailed
molecular level.
While the precise nature of the epimerisation process
remains to be de¢ned, the factor that di¡erentiates one
module from another in this respect is associated with
the KS domain. The results presented here demonstrate
that epimerisation activity can be transferred from one
module to another by genetic engineering but, depending
on the character of the receptor module, the stereochem-
ical outcome of subsequent reduction steps may be both
surprising and unexpected to the extent that an anti prod-
uct is formed by a KR domain which normally forms a
syn product (cf. [29]).
3. Signi¢cance
Modular PKSs are potentially valuable for the biosyn-
thesis of novel complex polyketides and many successful
modi¢cations to the structure have been achieved to date.
In contrast, there have been few modi¢cations to stereo-
chemistry at hydroxyl centres and none at all at methyl
branching centres. The results here show that the KS do-
main plays a key role in control of stereochemistry at
2 The assignment of C-4 as either R or S in the open chain form of the
triketides discussed in this work is opposite to the assignment of the
corresponding carbon centre in the lactone form. This does not in-
dicate an inversion at C-4, but is merely a consequence of the rules of
priority used to de¢ne R or S to a particular stereocentre. There has
been confusion on this point in some of the earlier literature.
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methyl branching sites and that methyl stereochemistry
can be altered by transfer of an appropriate KS domain.
Of equal signi¢cance is the demonstration that KR do-
mains di¡er from one another in their ¢delity when faced
with unnatural substrates. Some KR domains, such as
KR5 and KR6 in this work, cannot be relied upon to
carry out keto ester reduction, either in their normal con-
¢gurational sense or with their normal ¢delity. In one of
our constructs a module is allowed to produce both syn
and anti products. This appreciation of the underlying
factors determining stereochemical outcome may help to
explain why, despite con¢dent predictions, some engi-
neered PKSs have failed to produce the expected product.
4. Materials and methods
4.1. Strains and plasmids
S. erythraea/JC2 was maintained as described previously [28].
Routine cloning and transformation procedures were as previ-
ously described for E. coli [34] and for Streptomyces [35,36].
Chemicals were of analytical grade or the best commercially
available. Electrocompetent cells of E. coli DH10B strain were
made as described previously [37]. X-gal was obtained from No-
vabiochem. Agarose (electrophoresis grade) was obtained from
Life Technologies Inc., casamino acids and tryptone were from
Difco laboratories. Glucidex (MD30E), soya £our and beet mo-
lasses for SM3 culture media were the kind gifts of Glaxo Well-
come, UK. All antibiotics were bought from Sigma Chemical
Company, St. Louis, MO, USA.
4.2. DNA manipulations
PCR reactions were performed on a programmable Robo Cy-
cler Gradient 40 (Stratagene, USA) according to a modi¢cation
of a protocol described earlier [38]. Automated DNA sequencing
was carried out on double-stranded DNA templates using an
automated ABI 373A sequencer (Applied Biosystems). RecA pro-
tein was purchased from Promega.
4.3. Chemical analysis
1H NMR spectra were recorded at 600 MHz on a Bruker
DRX-600, at 500 MHz on a Bruker DRX-500, at 400 MHz on
a Bruker AM-400 or Bruker DRX-400, and at 250 MHz on a
Bruker AC-250. 13C NMR spectra were recorded at 100 MHz on
a Bruker AM-400 or at 400 MHz on a Bruker DRX-400. 1H and
13C NMR spectra were referenced internally to CHCl3 (7.27 and
77.5 ppm respectively). Chromatography was carried out using
Merck Kieselgel 60 (40^63 Wm). GC-MS was performed on a
Finnigan MAT GCQ instrument. Analytical and preparative re-
verse phase HPLC-MS analysis was carried out using Phenom-
enex Prodigy 5W ODS3 100 Aî columns with the following dimen-
sions: 250 mmU4.6 mm (analytical), 250 mmU10.0 mm (semi-
preparative) and 250 mmU21.2 mm (preparative) on a Finnigan
MAT LCQ instrument. Mass spectra were recorded on a Kratos
MS 890 double focussing magnetic sector MS (EI) and a Bruker
Bio Apex II Fourier transform ion cyclotron resonance (FT-ICR,
4.7 T), (ESI). Solvents were dried under standard conditions.
4.4. Growth medium
Special medium 3 (SM3) (for 1 l) ; glucose 5 g, MD30E-gluci-
dex 50 g, soya bean £our 25 g, beet molasses 3 g, K2HPO4 0.25 g,
CaCO3 2.5 g, Milli-Q water to 1 l and pH adjusted to 7.0 with
KOH.
4.5. Construction of plasmid pKS5
The 513 bp fragment of the gene encoding ery module 5 ex-
tending from nucleotide 12 069 to nucleotide 12 566 of eryAIII [1]
was ampli¢ed by PCR, and the PCR product inserted in SmaI-
cut/dephosphorylated pUC18. The oligonucleotides 5P-AAGCT-
CAGCATCAAGCTTCGGCATCAGCGGCACCAAC-3P and
5P-GCCGCTGAGCAGGTCGGTCAGCGACCAGTC-3P were
used as primers. A unique HindIII site was engineered in the
forward primer. The PCR product was precipitated and ligated
to the SmaI-cut pUC-18 vector and E. coli DH10B cells were
transformed with the ligation mixture. Selected colonies were
screened for their plasmid content using ampicillin as the resis-
tance marker. Plasmid pKS5 was identi¢ed by its restriction map
and subsequently sequenced using pUC forward and reverse
primers to check for misincorporation of nucleotides during
PCR. The 513 bp sequence was found to be accurate.
4.6. Construction of plasmid pKS5A
Plasmid pKS5 was cut with BlpI and the 513 bp fragment
containing the unique HindIII site was ligated to the vector
pARE24 that had been cut with BlpI. Plasmid pARE24 contains
the DEBS3 gene fused at its 5P-end with the ery loading module,
and its construction is described elsewhere [29]. E. coli DH10B
cells were transformed with the ligation mixture and selected
colonies were screened for their plasmid content. The desired
plasmid pKS5A was identi¢ed by restriction mapping.
4.7. Construction of the expression plasmid pO15-5624
Plasmid pKS5A was cut with HindIII and the 9.2 kbp fragment
containing the gene encoding DEBS3 (minus the KS5 domain)
was ligated to the vector pIBO15 [24] that had been cut with
HindIII. E. coli DH10B cells were transformed with the ligation
mixture and selected colonies were screened for their plasmid
content. The desired plasmid pO15-5624 was identi¢ed by restric-
tion mapping [30,39].
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